Millennium Management
RAPT

Millennium Management’s RAPT Therapeutics RAPT Stock Holding History

Millennium Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,375
Closed -$2.08M – 7279
2021
Q3 		$2.08M Buy
+8,375
New +$2.21M ﹤0.01% 3856
2021
Q2 		– Sell
-2,163
Closed -$384K – 7000
2021
Q1 		$384K Buy
+2,163
New +$357K ﹤0.01% 5038

Millennium Management's RAPT Position: Q1 2026 in Review

Millennium Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 106,671 shares — an estimated $3.61M sold.

Millennium Management first reported a position in RAPT in Q1 2020 and held it in 24 quarters. The position peaked at $15.4M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

  • Millennium Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 106,671 RAPT Therapeutics shares in Q1 2026, an estimated $3.61M.
  • Millennium Management first reported a position in RAPT Therapeutics in Q1 2020 and held it in 24 quarters.
  • Millennium Management's RAPT Therapeutics position peaked at $15.4M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.